Influence of Technological Treatments on the Functionality of Bifidobacterium lactis INL1, a Breast Milk-Derived Probiotic

Journal of Food Science

Volumn 82, Issue 10, 2017, Pages 2462-2470

  Zacarías, María Florencia ^a   Souza, Tassia Costa ^a   Zaburlín, Natalia ^a   Carmona Cara, Denise ^b   Reinheimer, Jorge ^a   Nicoli, Jacques ^b   Vinderola, Gabriel ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bifidobacterium lactis; functionality; probiotic; Salmonella; technology

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; PROBIOTIC AGENT;

ANIMAL; BAGG ALBINO MOUSE; BIFIDOBACTERIUM; BREAST MILK; CHEMISTRY; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; MOUSE; PHYSIOLOGY; SALMONELLA; SALMONELLOSIS; SMALL INTESTINE;

ANIMALS; BIFIDOBACTERIUM; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTESTINE, SMALL; MALE; MICE; MICE, INBRED BALB C; MILK, HUMAN; PROBIOTICS; SALMONELLA; SALMONELLA INFECTIONS;

EID: 85029234340     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/1750-3841.13852     Document Type: Article

References (45)

1. Awoniyi M, Miller SI, Wilson CB, Hajjar AM, Smith KD. 2012. Homeostatic regulation of Salmonella-induced mucosal inflammation and injury by IL-23. PLoS ONE 7(5):e37311.
2. Burns P, Alard J, Hrdy J, Boutillier D, Páez R, Reinheimer J, Pot B, Vinderola G, Grangette C. 2017. Spray-drying effect on the protective capacity of the breast milk-derived Bifidobacterium lactis INL1 on acute and chronic colitis in mice. Sci Rep 7:43211.
3. Cerutti A, Rescigno M. 2008 The biology of intestinal immunoglobulin: a responses. Immunity 28(6):740–50.
4. Charnchai P, Jantama SS, Prasitpuriprecha C, Kanchanatawee S, Jantama K. 2016. Effects of the food manufacturing chain on the viability and functionality of Bifidobacterium animalis through simulated gastrointestinal conditions. PLoS One 11(6):e0157958.
5. Cheikhyoussef A, Pogori N, Chen W, Zhang H. 2008 Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application. Int J Food Microbiol 125(3):215–22.
6. Cinque B, La Torre C, Lombardi F, Palumbo P, Van der Rest M, Cifone MG. 2016. Production conditions affect the in vitro anti-tumoral effects of a high concentration multi-strain probiotic preparation. PLoS ONE 11(9):e0163216.
7. de Kivit S, Tobin MC, Forsyth CB, Keshavarzian A, Landay AL. 2014. Regulation of intestinal immune responses through TLR activation: implications for pro- and prebiotics. Front Immunol 5:60.
8. de Moreno de LeBlanc A, Chaves S, Carmuega E, Weill R, Antóine J, Perdigón G. 2008. Effect of long-term continuous consumption of fermented milk containing probiotic bacteria on mucosal immunity and the activity of peritoneal macrophages. Immunobiol 213(2):97–108.
9. de Moreno de LeBlanc A, Castillo NA, Perdigón G. 2010. Anti-infective mechanisms induced by a probiotic Lactobacillus strain against Salmonella enterica serovar Typhimurium infection. Int J Food Microbiol 138(3):223–31.
10. du Toit E, Vesterlund S, Gueimonde M, Salminen S. 2013. Assessment of the effect of stress-tolerance acquisition on some basic characteristics of specific probiotics. Int J Food Microbiol 165(1):51–6.
11. Ellis TN, Beaman BL. 2004. Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology 112(1):2–12.
12. Floch MH. 2014. Recommendations for probiotic use in humans: a 2014 update. Pharmaceuticals 7(10):999–1007.
13. Greaves P. 2012. Digestive system. In Histopathology of preclinical toxicity studies: interpretation and relevance in drug safety evaluation. 4th ed. Amsterdam: Academic Press. p 325–422.
14. Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P, Campieri M, Kamm MA, Knight SC, Stagg AJ. 2004. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53(11):1602–9.
15. Hoy YE, Bik EM, Lawley TD, Holmes SP, Monack DM, Theriot JA, Relman DA. 2015. Variation in taxonomic composition of the fecal microbiota in an inbred mouse strain across individuals and time. PLoS One 10(11):e0142825.
16. Hu S, Yang K, Yang J, Li M, Xiong N. 2011. Critical roles of chemokine receptor CCR10 in regulating memory IgA responses in intestines. Proc Natl Acad Sci U S A 108(45):E1035–44.
17. Jankovic I, Sybesma W, Phothirath P, Ananta E, Mercenier A. 2010. Application of probiotics in food products-challenges and new approaches. Curr Opin Biotechnol 21(2):175–81.
18. Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H, Tsuji NM, Kiyono H, Ma JS, Kusu T, Okumura R, Hara H, Yoshida H, Yamamoto M, Nomoto K, Takeda K. 2012. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog 8(5):e1002714.
19. Johansson MA, Saghafian-Hedengren S, Haileselassie Y, Roos S, Troye-Blomberg M, Nilsson C, Sverremark-Ekström E. 2012. Early-life gut bacteria associate with IL-4-, IL-10- and IFN-γ production at two years of age. PLoS One 7(11), e49315.
20. Kaiser P, Diard M, Stecher B, Hardt WD. 2012. The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen's virulence factors, and the host's mucosal immune response. Immunol Rev 245(1):56–83.
21. Kekkonen RA, Lummela N, Karjalainen H, Latvala S, Tynkkynen S, Jarvenpaa S, Kautiainen H, Julkunen I, Vapaatalo H, Korpela R. 2008. Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 14(13):2029–36.
22. Lapaque N, Walzer T, Méresse S, Vivier E, Trowsdale J. 2009. Interactions between human NK cells and macrophages in response to Salmonella infection. J Immunol 182(7):4339–48.
23. Macpherson AJ, Hunziker L, McCoy K, Lamarre A. 2001. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes Infect 3:1021–35.
24. Marchi LF, Sesti-Costa R, Ignacchiti MD, Chedraoui-Silva S, Mantovani B. 2014. In vitro activation of mouse neutrophils by recombinant human interferon-gamma: increased phagocytosis and release of reactive oxygen species and pro-inflammatory cytokines. Int Immunopharmacol 18(2):228–35.
25. Mesin L, Di Niro R, Thompson KM, Lundin KE, Sollid LM. 2011. Long-lived plasma cells from human small intestine biopsies secrete immunoglobulins for many weeks in vitro. J. Immunol 187:2867–74.
26. Mileti E, Matteoli G, Iliev ID, Rescigno M. 2009. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One 4(9):e7056.
27. Nardi RD, Santos ARM, Carvalho MAR, Farias LM, Benchetrit LC, Nicoli JR. 1999. Antagonism against anaerobic and facultative bacteria through a diffusible inhibitory compound produced by a Lactobacillus sp. isolated from the rat fecal microbiota. Anaerobe 5:409–11.
28. Peterson LW, Artis D. 2014. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 14(3):141–53.
29. Rausch P, Basic M, Batra A, Bischoff SC, Blaut M, Clavel T, Gläsner J, Gopalakrishnan S, Grassl GA, Günther C, Haller D, Hirose M, Ibrahim S, Loh G, Mattner J, Nagel S, Pabst O, Schmidt F, Siegmund B, Strowig T, Volynets V, Wirtz S, Zeissig S, Zeissig Y, Bleich A, Baines JF. 2016. Analysis of factors contributing to variation in the C57BL/6J fecal microbiota across German animal facilities. Int J Med Microbiol 306(5):343–55.
30. Rescigno M. 2013. Mucosal immunology and bacterial handling in the intestine. Best Pract Res Clin Gastroenterol 27(1):17–24.
31. Rodrigues AC, Cara DC, Fretez SH, Cunha FQ, Vieira EC, Nicoli JR, Vieira LQ. 2000. Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 89(3):404–14.
32. Roller M, Rechkemmer G, Watzl B. 2004. Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats. J Nutr 134(1):153–6.
33. Russell DA, Ross RP, Fitzgerald GF, Stanton C. 2011. Metabolic activities and probiotic potential of bifidobacteria. Int J Food Microbiol 149(1):88–105.
34. Saarela M, Virkajarvi I, Alakomi HL, Sigvart-Mattila P, Mättö J. 2006. Stability and functionality of freeze-dried probiotic Bifidobacterium cells during storage in juice and milk. Int Dairy J 16:1477–82.
35. Saarela MH, Alakomi HL, Puhakka A, Mättö J. 2009. Effect of the fermentation pH on the storage stability of Lactobacillus rhamnosus preparations and suitability of in vitro analyses of cell physiological functions to predict it. J Appl Microbiol 106:1204–12.
36. Sanders ME, Klaenhammer TR, Ouwehand AC, Pot B, Johansen E, Heimbach JT, Marco ML, Tennilä J, Ross RP, Franz C, Pagé N, Pridmore RD, Leyer G, Salminen S, Charbonneau D, Call E, Lenoir-Wijnkoop I. 2014. Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics. Ann N Y Acad Sci 1309:1–18.
37. Saxelin M, Tynkkynen S, Mattila-Sandholm T, de Vos WM. 2005. Probiotic and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol 16(2):204–11.
38. Sousa S, Gomes AM, Pintado MM, Silva JP, Costa P, Amaral MH, Duarte AC, Rodrigues D, Rocha-Santos TAP, Freitas AC. 2015. Characterization of freezing effect upon stability of probiotic loaded, calcium-alginate microparticles. Food Bioprod Process 93:90–7.
39. Souza TC, Silva AM, Drews JRP, Gomes DA, Vinderola G, Nicoli J. 2013. In vitro evaluation of Bifidobacterium strains of human origin for probiotics functional foods. Benef Microbes 4:179–86.
40. Suzuki K, Nakajima A. 2014. New aspects of IgA synthesis in the gut. Int Immunol 26(9):489–94.
41. Vieira EL, Leonel AJ, Sad AP, Beltrão NR, Costa TF, Ferreira TM, Gomes-Santos AC, Faria AM, Peluzio MC, Cara DC, Alvarez-Leite JI. 2012. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J Nutr Biochem 23(5):430–6.
42. Vinderola CG, Duarte J, Thangavel D, Perdigón G, Farnworth E, Matar C. 2005. Immunomodulating capacity of kefir. J Dairy Res 72:195–202.
43. Vinderola G, Zacarías MF, Bockelmann W, Neve H, Reinheimer J, Heller KJ. 2012. Preservation of functionality of Bifidobacterium animalis subsp. lactis INL1 after incorporation of freeze-dried cells into different food matrices. Food Microbiol 30(1):274–80.
44. Zacarías MF, Binetti A, Laco M, Reinheimer J, Vinderola G. 2011. Preliminary technological and probiotic characterization of bifidobacteria isolated from breast milk for use in dairy products. Int Dairy J 21:548–55.
45. Zacarías MF, Reinheimer J, Forzani L, Grangette C, Vinderola G. 2014. Mortality and translocation assay to study the protective capacity of Bifidobacterium lactis INL1 against Salmonella Typhimurium infection in mice. Benef Microbes 5(4):427–36.